Why the study?
What are the IMT and aPWV values in obese adolescents with type 2 diabetes, and how do they relate to clinical and metabolic risk factors of CVD?
What are the IMT and aPWV values in obese adolescents with type 2 diabetes, and how do they relate to clinical and metabolic risk factors of CVD?
This pilot study aims to evaluate early surrogate markers of atherosclerosis (IMT and aPWV) in obese adolescents with type 2 diabetes to understand early cardiovascular disease progression.
No takes yet. Share an insight, caveat, or question.
Does not alter clinical management in obese adolescents with type 2 diabetes; leaves open the prognostic role of IMT and aPWV.
Gungor et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: